Several recent GWAS and a parallel candidate gene study reported consistent associations between variants in the FOXE1 region (rs965513, rs1867277, rs7850258) and risk of papillary thyroid cancer and/or primary hypothyroidism [9]–[11], [41], [42]. This evidence concerns the gene FOXE1 and thyroid gland papillary carcinoma.